An Official Website of the United States Government
Company Information:
Name:
DOR BIOPHARMA, INC.
Address:
29 Emmons Dr
PRINCETON, NJ 08540-
PRINCETON, NJ 08540-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Enteric-Coated Oral Beclomethasone Dipropionate in Patients with Acute Enteritis
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Christopher J. Schaber
Award Amount:
$509,870.00
Abstract:
DESCRIPTION (provided by applicant): Acute radiation enteritis is caused by radiation-induced death of the normal cells in the lining of the bowel. As bowel cells die and are not replaced, gastrointestinal toxicity develops over the next few days and w
eeks with chronic diarrhea, vomiting and… More
Beclomethasone post exposure therapy for gastrointestinal acute radiation syndrom
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Kevin J. Horgan – 310-206-3580
Award Amount:
$600,000.00
Abstract:
DESCRIPTION (provided by applicant): This proposal concerns the use of beclomethasone dipropionate (BDP) as a post-exposure drug therapy having the potential to mitigate the gastrointestinal (GI) injury associated with acute radiation syndrome (ARS) following exposure to intense ionizing radiation.… More
IND 20212 (03-25-99) PHASE 2: ORBEC (ORAL BDP)-PATIENTS WITH CHRONIC GVHD
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Kevin J. Horgan – 310-206-3580
Award Amount:
$300,000.00
Abstract:
DESCRIPTION (provided by applicant): Graft vs. Host Disease (GVHD) is an expensive life-threatening complication following allogeneic hematopoietic cell transplantation in some patients that receive this life-saving treatment for certain cancers. The proposed open-label, multi-center, two-part… More